Education Secretary Miguel Cardona said Monday that Puerto Rico will receive nearly $4 billion in federal education pandemic relief funds to help boost the U.S. territory?s fight against COVID-19. SAN JUAN, Puerto Rico (AP) - U.S.
Selpercatinib is the first drug from Loxo's pipeline that Lilly has brought to market. Prior to the acquisition, Loxo won approval of Vitrakvi, which targets a different genetic mutation and is sold by Bayer AG.
Selpercatinib is the first drug from Loxo's pipeline that Lilly has brought to market. Prior to the acquisition, Loxo won approval of Vitrakvi, which targets a different genetic mutation and is sold by Bayer AG.
Selpercatinib is the first drug from Loxo's pipeline that Lilly has brought to market. Prior to the acquisition, Loxo won approval of Vitrakvi, which targets a different genetic mutation and is sold by Bayer AG.
SAN JUAN, Puerto Rico (AP) - U.S. Education Secretary Miguel Cardona said Monday that Puerto Rico will receive nearly $4 billion in federal education pandemic relief funds to help boost the U.S. territory?s fight against COVID-19.
Although the company will continue to pursue "higher-risk, high reward" drug candidates such as pegilodecakin, these will be a smaller part of the portfolio in the future, said Chief Scientific Officer Daniel Skovronsky.
Nicholas Hewlett, head of St Dunstan's College private school in southeast London, said staff were worried by a 'righteous generation' of children who were looking for their teachers to 'trip up' on even 'small, persistent slights'.
In the UK, the pandemic and a crackdown on immigration following Brexit contributed to unpredictable supplies of fruits, vegetables and prepared foods in stores and restaurant chains, said Shane Brennan, chief executive at the Cold Chain Federation.
In the UK, the pandemic and a crackdown on immigration following Brexit contributed to unpredictable supplies of fruits, vegetables and prepared foods in stores and restaurant chains, said Shane Brennan, chief executive at the Cold Chain Federation.